Company Filing History:
Years Active: 2020
Title: Lars Matthias Ittner: Innovator in Tauopathy Research
Introduction
Lars Matthias Ittner is a notable inventor based in Chatswood, Australia. He has made significant contributions to the field of biomedical research, particularly in the study of tauopathies, which are neurodegenerative diseases associated with the accumulation of tau protein in the brain. His innovative work has led to the development of methods and assays that could pave the way for new therapeutic approaches.
Latest Patents
Lars Matthias Ittner holds a patent for an "Assay and method for identifying compounds that reduce SIL1 expression or activity." This invention relates to methods and assays designed to identify compounds as potential candidates for drug development aimed at treating various diseases, including those associated with pathological tau. The patent also encompasses cell lines and constructs that can be utilized in the assays, providing a comprehensive approach to identifying compounds that modulate Sil1 expression or activity.
Career Highlights
Ittner is affiliated with Macquarie University, where he continues to advance his research in the field of tauopathies. His work is crucial in understanding the underlying mechanisms of these diseases and developing effective treatments.
Collaborations
Lars Matthias Ittner has collaborated with notable colleagues, including Janet Van Eersel and Arne Anselm Ittner. These collaborations enhance the research efforts and contribute to the advancement of knowledge in the field.
Conclusion
Lars Matthias Ittner's contributions to tauopathy research through his innovative patent and collaborative efforts at Macquarie University highlight his role as a significant figure in the scientific community. His work has the potential to lead to breakthroughs in the treatment of neurodegenerative diseases.